These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
570 related articles for article (PubMed ID: 14505137)
41. [Severe exacerbation of chronic hepatitis B during therapy with corticosteroids and lamivudine therapy and successful short-term combination therapy with interferon-beta and interferon-gamma]. Musch E; Malek M; Chrissafidou A Z Gastroenterol; 2003 May; 41(5):425-8. PubMed ID: 12772056 [TBL] [Abstract][Full Text] [Related]
42. Hepatitis and HIV infection during haemodialysis. Saha D; Agarwal SK J Indian Med Assoc; 2001 Apr; 99(4):194-9, 203, 213. PubMed ID: 11666025 [TBL] [Abstract][Full Text] [Related]
43. Treatment of HBV/HCV coinfection. Potthoff A; Manns MP; Wedemeyer H Expert Opin Pharmacother; 2010 Apr; 11(6):919-28. PubMed ID: 20166841 [TBL] [Abstract][Full Text] [Related]
44. Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection. Coppola N; Pisapia R; Tonziello G; Martini S; Imparato M; Piai G; Stanzione M; Sagnelli C; Filippini P; Piccinino F; Sagnelli E Antivir Ther; 2008; 13(2):307-18. PubMed ID: 18505182 [TBL] [Abstract][Full Text] [Related]
46. [Interferon therapy of chronic viral hepatitis in Hungary: 5-year experience. A multicenter study]. Pár A; Telegdy L; Gógl A; Müller E Orv Hetil; 1999 May; 140(22):1227-33. PubMed ID: 10377733 [TBL] [Abstract][Full Text] [Related]
47. Natural history of hepatitis C and the impact of anti-viral therapy. Boyer N; Marcellin P Forum (Genova); 2000; 10(1):4-18. PubMed ID: 10717254 [TBL] [Abstract][Full Text] [Related]
49. [Clinical and virological course of dual infection by hepatitis B and C viruses in China]. Fan CL; Wei L; Jiang D; Chen HS; Gao Y; Li RB; Fei R; Ji Y; Zhu L; Wang Y Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1214-8. PubMed ID: 12930633 [TBL] [Abstract][Full Text] [Related]
50. The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection. Potthoff A; Wedemeyer H; Boecher WO; Berg T; Zeuzem S; Arnold J; Spengler U; Gruengreiff K; Kaeser T; Schuchmann M; Bergk A; Forestier N; Deterding K; Manns MP; Trautwein C; J Hepatol; 2008 Nov; 49(5):688-94. PubMed ID: 18490077 [TBL] [Abstract][Full Text] [Related]
51. Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial. Mazzella G; Saracco G; Festi D; Rosina F; Marchetto S; Jaboli F; Sostegni R; Pezzoli A; Azzaroli F; Cancellieri C; Montagnani M; Roda E; Rizzetto M Am J Gastroenterol; 1999 Aug; 94(8):2246-50. PubMed ID: 10445557 [TBL] [Abstract][Full Text] [Related]
52. Occult hepatitis B infection in Portuguese patients with chronic hepatitis C liver disease: prevalence and clinical significance. Cardoso C; Alves AL; Augusto F; Freire R; Quintana C; Gonçalves M; Oliveira AP Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):142-6. PubMed ID: 23044809 [TBL] [Abstract][Full Text] [Related]
53. Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C. Mrani S; Chemin I; Menouar K; Guillaud O; Pradat P; Borghi G; Trabaud MA; Chevallier P; Chevallier M; Zoulim F; Trépo C J Med Virol; 2007 Aug; 79(8):1075-81. PubMed ID: 17596829 [TBL] [Abstract][Full Text] [Related]
55. Clearance of hepatitis C viral RNA in cirrhotic patients with antiviral therapy. Ono SK; da Silva LC; Carrilho FJ; da Fonseca LE; Mendes LC; Madruga CL; Farias Ade Q; Laudanna AA Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(5):180-3. PubMed ID: 9216095 [TBL] [Abstract][Full Text] [Related]
56. Increased risk of chronic hepatitis in children with cancer. Sevinir B; Meral A; Günay U; Ozkan T; Ozuysal S; Sinirtas M Med Pediatr Oncol; 2003 Feb; 40(2):104-10. PubMed ID: 12461794 [TBL] [Abstract][Full Text] [Related]
57. HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals. Calvaruso V; Ferraro D; Licata A; Bavetta MG; Petta S; Bronte F; Colomba G; Craxì A; Di Marco V J Viral Hepat; 2018 Jan; 25(1):72-79. PubMed ID: 28703895 [TBL] [Abstract][Full Text] [Related]
58. Comparison of three commercially available assays for HCV RNA using the international unit standard: implications for management of patients with chronic hepatitis C virus infection in clinical practice. Shiffman ML; Ferreira-Gonzalez A; Reddy KR; Sterling RK; Luketic VA; Stravitz RT; Sanyal AJ; Garrett CT; De Medina M; Schiff ER Am J Gastroenterol; 2003 May; 98(5):1159-66. PubMed ID: 12809843 [TBL] [Abstract][Full Text] [Related]
59. Combined interferon and ribavirin therapy for chronic hepatitis C in Taiwan. Lai MY Intervirology; 2006; 49(1-2):91-5. PubMed ID: 16166795 [TBL] [Abstract][Full Text] [Related]
60. Hepatitis B virus and hepatitis C virus co-infection: a therapeutic challenge. Hamzaoui L; El Bouchtili S; Siai K; Mahmoudi M; Azzouz MM Clin Res Hepatol Gastroenterol; 2013 Feb; 37(1):e16-20. PubMed ID: 22959099 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]